LEGISLATIVE BUDGET BOARD
Austin, Texas
 
FISCAL NOTE, 86TH LEGISLATIVE REGULAR SESSION
 
April 12, 2019

TO:
Honorable Senfronia Thompson, Chair, House Committee on Public Health
 
FROM:
John McGeady, Assistant Director     Sarah Keyton, Assistant Director
Legislative Budget Board
 
IN RE:
HB4055 by Wu (Relating to the availability under Medicaid of certain drugs used to treat human immunodeficiency virus or prevent acquired immune deficiency syndrome.), Committee Report 1st House, Substituted

No significant fiscal implication to the State is anticipated.

The bill would prohibit the Health and Human Services Commission (HHSC), or managed care organizations, from requiring certain actions in Medicaid related to dispensing of antiretroviral drugs. According to HHSC, there would be no fiscal impact associated with implementation of the provisions of the bill as they do not differ from current policy.

Local Government Impact

No fiscal implication to units of local government is anticipated.


Source Agencies:
529 Health and Human Services Commission
LBB Staff:
WP, AKi, LR